Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-18-002514

Options or other derivatives

  • President and CSO acquired 175,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Tepper Mark · President and CSO

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-01-04 Grant or award : show line 1 in the form Stock Option(right to buy) +175,000 $8.35 2028-01-04 175,000 175,000 D
Loading xslF345X03/doc4.xml…